Inhibition of Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 (MK2) is Protective in Pulmonary Hypertension.
Animals
Apoptosis
/ drug effects
Cell Proliferation
Cells, Cultured
Enzyme Inhibitors
/ pharmacology
Humans
Hypertension, Pulmonary
/ metabolism
Hypoxia
/ metabolism
Inflammation
/ metabolism
Intracellular Signaling Peptides and Proteins
/ antagonists & inhibitors
Muscle, Smooth, Vascular
/ metabolism
Oxidative Stress
/ drug effects
Peptides
/ pharmacology
Protein Serine-Threonine Kinases
/ antagonists & inhibitors
Pulmonary Artery
/ metabolism
Rats
Rats, Sprague-Dawley
Vascular Remodeling
/ drug effects
cardiovascular diseases
hypoxia
inflammation
mitogen-activated protein kinase
monocrotaline
pulmonary hypertension
Journal
Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
pubmed:
2
3
2021
medline:
7
9
2021
entrez:
1
3
2021
Statut:
ppublish
Résumé
[Figure: see text].
Identifiants
pubmed: 33641361
doi: 10.1161/HYPERTENSIONAHA.120.15229
doi:
Substances chimiques
Enzyme Inhibitors
0
Intracellular Signaling Peptides and Proteins
0
MMI-0100
0
Peptides
0
MAP-kinase-activated kinase 2
EC 2.7.1.-
Protein Serine-Threonine Kinases
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM